Scynexis (SCYX) Interest & Investment Income (2013 - 2026)
Scynexis (SCYX) reported Interest & Investment Income of $535000.0 for Q1 2026, down 31.06% on a YoY basis from $776000.0 in Q1 2025, and up 27.99% quarter-over-quarter from $418000.0 in Q4 2025.
Scynexis (SCYX) Interest & Investment Income (2013 - 2026) Analysis & Trends
Scynexis has reported Interest & Investment Income for 14 years, with the latest figure at $535000.0 in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income fell 31.06% year-over-year to $535000.0; the trailing twelve-month figure through Mar 2026 stood at $1.9 million (down 49.49% YoY), and the FY2025 full-year result was $2.2 million, down 49.27% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $535000.0, up from $418000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $1.4 million in Q4 2023, with the low at $13000.0 in Q1 2022.
- Historically, Interest & Investment Income has averaged $727000.0 across 5 years, with a median of $691000.0 in 2022.
- Annual changes were most pronounced in 2022 — Interest & Investment Income surged 17175.0% — and 2025, when it plunged 55.49%.
- Scynexis' Interest & Investment Income stood at $691000.0 in 2022, then soared by 97.4% to $1.4 million in 2023, then sank by 36.29% to $869000.0 in 2024, then slumped by 51.9% to $418000.0 in 2025, then grew by 27.99% to $535000.0 in 2026.
- The last three Interest & Investment Income figures came in at $535000.0 (Q1 2026), $418000.0 (Q4 2025), and $454000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 41.80 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 28.10 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 8.54 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 4.97 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | - |
| 10 | Scynexis | 216.06 Mn | 156.80 Mn | - | 535,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 535,000.00 |
| Dec 31, 2025 | 418,000.00 |
| Sep 30, 2025 | 454,000.00 |
| Jun 30, 2025 | 510,000.00 |
| Mar 31, 2025 | 776,000.00 |
| Dec 31, 2024 | 869,000.00 |
| Sep 30, 2024 | 1.02 Mn |
| Jun 30, 2024 | 1.13 Mn |
| Mar 31, 2024 | 1.28 Mn |
| Dec 31, 2023 | 1.36 Mn |
| Sep 30, 2023 | 1.26 Mn |
| Jun 30, 2023 | 737,000.00 |
| Mar 31, 2023 | 587,000.00 |
| Dec 31, 2022 | 691,000.00 |
| Sep 30, 2022 | 531,000.00 |
| Jun 30, 2022 | 181,000.00 |
| Mar 31, 2022 | 13,000.00 |
| Dec 31, 2021 | 4,000.00 |
| Sep 30, 2021 | 8,000.00 |
| Jun 30, 2021 | 6,000.00 |